SYN-608

N/A

Report date: 2025/07/29 20:00:11
NME

Base Information

Drug NameSYN-608
Drug Alias NameSYN-608
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly(ADP-ribose) glycohydrolase inhibitors
TargetsPoly(ADP-ribose) glycohydrolase
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSynrx Therapeutics (Hangzhou) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSynrx Therapeutics (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursOvarian NeoplasmsBreast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A